DDX3X and hepatitis B virus infection: In liver hepatocellular cells, previous findings indicated that 5-HT treatment could augment 5-HT receptor 7-mediated DDX3X promoter activity as well as the induction of an innate immunity to abolish hepatitis B virus (HBV) infection [27].